Deep brain stimulation for extreme behaviors associated with autism spectrum disorder converges on a common pathway: a systematic review and connectomic analysis

Han YanDivision of Neurosurgery, Department of Surgery, University of Toronto;
Division of Neurosurgery, The Hospital for Sick Children, Toronto;
Institute of Health Policy, Management and Evaluation, University of Toronto, Ontario;

Search for other papers by Han Yan in
Current site
Google Scholar
PubMed
Close
 MD
,
Lior M. ElkaimDivision of Neurosurgery, McGill University, Montreal, Quebec;

Search for other papers by Lior M. Elkaim in
Current site
Google Scholar
PubMed
Close
 MD
,
Flavia Venetucci GouveiaBiological Sciences, Sunnybrook Research Institute, Toronto;

Search for other papers by Flavia Venetucci Gouveia in
Current site
Google Scholar
PubMed
Close
 PhD
,
Joelene F. HuberDivisions of Paediatric Medicine and Developmental Paediatrics, Department of Paediatrics, The Hospital for Sick Children, Toronto;

Search for other papers by Joelene F. Huber in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
Jurgen GermannUniversity Health Network, Toronto, Ontario, Canada;

Search for other papers by Jurgen Germann in
Current site
Google Scholar
PubMed
Close
 PhD
,
Aaron LohUniversity Health Network, Toronto, Ontario, Canada;

Search for other papers by Aaron Loh in
Current site
Google Scholar
PubMed
Close
 BCh, BAO
,
Juan Carlos Benedetti-IsaacStereotactic and Functional Neurosurgery Division, International Misericordia Clinic, Barranquilla, Colombia;

Search for other papers by Juan Carlos Benedetti-Isaac in
Current site
Google Scholar
PubMed
Close
 MD
,
Paresh K. DoshiDepartment of Stereotactic and Functional Neurosurgery, Jaslok Hospital and Research Centre, Mumbai, India;

Search for other papers by Paresh K. Doshi in
Current site
Google Scholar
PubMed
Close
 MCh
,
Cristina V. TorresDepartment of Neurosurgery, University Hospital La Princesa, Madrid, Spain;

Search for other papers by Cristina V. Torres in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
David J. SegarDepartment of Neurosurgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts;

Search for other papers by David J. Segar in
Current site
Google Scholar
PubMed
Close
 MD
,
Gavin J. B. EliasUniversity Health Network, Toronto, Ontario, Canada;

Search for other papers by Gavin J. B. Elias in
Current site
Google Scholar
PubMed
Close
 BA
,
Alexandre BoutetUniversity Health Network, Toronto, Ontario, Canada;
Joint Department of Medical Imaging, University of Toronto;

Search for other papers by Alexandre Boutet in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
G. Rees CosgroveDepartment of Neurosurgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts;

Search for other papers by G. Rees Cosgrove in
Current site
Google Scholar
PubMed
Close
 MD
,
Alfonso FasanoEdmond J. Safra Program in Parkinson’s Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Toronto;
Division of Neurology, University of Toronto;
Krembil Brain Institute, Toronto;

Search for other papers by Alfonso Fasano in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
Andres M. LozanoUniversity Health Network, Toronto, Ontario, Canada;
Joint Department of Medical Imaging, University of Toronto;

Search for other papers by Andres M. Lozano in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
Abhaya V. KulkarniDivision of Neurosurgery, Department of Surgery, University of Toronto;
Division of Neurosurgery, The Hospital for Sick Children, Toronto;
Institute of Health Policy, Management and Evaluation, University of Toronto, Ontario;

Search for other papers by Abhaya V. Kulkarni in
Current site
Google Scholar
PubMed
Close
 MD, PhD
, and
George M. IbrahimDivision of Neurosurgery, Department of Surgery, University of Toronto;
Division of Neurosurgery, The Hospital for Sick Children, Toronto;
Institute of Biomedical Engineering, University of Toronto; and
Institute of Medical Science, University of Toronto, Ontario, Canada

Search for other papers by George M. Ibrahim in
Current site
Google Scholar
PubMed
Close
 MD, PhD
View More View Less
Free access

OBJECTIVE

Individuals with autism spectrum disorder (ASD) may display extreme behaviors such as self-injury or aggression that often become refractory to psychopharmacology or behavioral intervention. Deep brain stimulation (DBS) is a surgical alternative that modulates brain circuits that have yet to be clearly elucidated. In the current study the authors performed a connectomic analysis to identify brain circuitry engaged by DBS for extreme behaviors associated with ASD.

METHODS

A systematic review was performed to identify prior reports of DBS as a treatment for extreme behaviors in patients with ASD. Individual patients’ perioperative imaging was collected from corresponding authors. DBS electrode localization and volume of tissue activated modeling were performed. Volumes of tissue activated were used as seed points in high-resolution normative functional and structural imaging templates. The resulting individual functional and structural connectivity maps were pooled to identify networks and pathways that are commonly engaged by all targets.

RESULTS

Nine patients with ASD who were receiving DBS for symptoms of aggression or self-injurious behavior were identified. All patients had some clinical improvement with DBS. Connectomic analysis of 8 patients (from the systematic review and unpublished clinical data) demonstrated a common anatomical area of shared circuitry within the anterior limb of the internal capsule. Functional analysis of 4 patients identified a common network of distant brain areas including the amygdala, insula, and anterior cingulate engaged by DBS.

CONCLUSIONS

This study presents a comprehensive synopsis of the evidence for DBS in the treatment of extreme behaviors associated with ASD. Using network mapping, the authors identified key circuitry common to DBS targets.

ABBREVIATIONS

ALIC = anterior limb of the internal capsule; ASD = autism spectrum disorder; DBS = deep brain stimulation; GPi = globus pallidus internus; JHMRS = Johns Hopkins motor stereotypy rating scale; NAcc = nucleus accumbens; OAS = Overt Aggression Scale; OCD = obsessive-compulsive disorder; pHyp = posterior hypothalamus; SIB = self-injurious behavior; VC/VS = ventral capsule/ventral striatum; VTA = volume of tissue activated.

OBJECTIVE

Individuals with autism spectrum disorder (ASD) may display extreme behaviors such as self-injury or aggression that often become refractory to psychopharmacology or behavioral intervention. Deep brain stimulation (DBS) is a surgical alternative that modulates brain circuits that have yet to be clearly elucidated. In the current study the authors performed a connectomic analysis to identify brain circuitry engaged by DBS for extreme behaviors associated with ASD.

METHODS

A systematic review was performed to identify prior reports of DBS as a treatment for extreme behaviors in patients with ASD. Individual patients’ perioperative imaging was collected from corresponding authors. DBS electrode localization and volume of tissue activated modeling were performed. Volumes of tissue activated were used as seed points in high-resolution normative functional and structural imaging templates. The resulting individual functional and structural connectivity maps were pooled to identify networks and pathways that are commonly engaged by all targets.

RESULTS

Nine patients with ASD who were receiving DBS for symptoms of aggression or self-injurious behavior were identified. All patients had some clinical improvement with DBS. Connectomic analysis of 8 patients (from the systematic review and unpublished clinical data) demonstrated a common anatomical area of shared circuitry within the anterior limb of the internal capsule. Functional analysis of 4 patients identified a common network of distant brain areas including the amygdala, insula, and anterior cingulate engaged by DBS.

CONCLUSIONS

This study presents a comprehensive synopsis of the evidence for DBS in the treatment of extreme behaviors associated with ASD. Using network mapping, the authors identified key circuitry common to DBS targets.

In Brief

Through this multicenter collaboration, a connectomic analysis was performed in patients with autism spectrum disorder (ASD) who manifested extreme behaviors and underwent deep brain stimulation (DBS). Stimulation of different targets engaged similar brain circuitry closely related to the anterior limb of the internal capsule. The current work elucidates putative mechanisms by which DBS could improve symptoms of extreme behaviors in patients with ASD.

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by persistent deficits in social communication and interaction and restricted, repetitive behaviors, interests, and/or activities.1,2 Extreme behaviors in patients with ASD include self-injurious behavior (SIB) or persistent episodes of aggression.3,4 A recent meta-analysis estimated a pooled prevalence of self-injury of 42% among patients with ASD, noting poor communication and developmental delay as additional risk factors.5,6 Both SIB and aggression can lead to physical harm, psychological stress, and increased healthcare resource utilization, and therefore may adversely affect the quality of life of patients and their caregivers.79

The consequences of extreme behaviors of patients with ASD are further compounded by the limited efficacy of psychopharmacology and by challenges in access to behavioral treatment. Expert consensus and small-cohort studies have supported the use of second-generation antipsychotics—particularly risperidone and aripiprazole—to target aggression or the irritability that may underlie SIB.1012 Applied behavioral analysis, including functional behavior assessment, has also met criteria as evidence-based practices for treating extreme behaviors by manipulating antecedents and reinforced consequences.13,14 However, the variation in efficacy and side effects of medications and the lack of accessibility of applied behavioral analysis limit the effectiveness of these treatments in real-world settings.15,16Alternative and innovative options are therefore increasingly sought, including deep brain stimulation (DBS).

DBS electrodes targeting the posterior hypothalamus (pHyp)17,18 and the nucleus accumbens (NAcc)19 have been used to treat aggression and SIB. However, the exact mechanism by which stimulation of these targets alters extreme behaviors in patients with ASD is not yet understood. It is likely that different DBS targets for extreme behaviors that are used in patients with ASD may engage common underlying neural circuitry. Recent connectivity modeling by Li et al.20 in patients with obsessive-compulsive disorder (OCD) demonstrated that optimal clinical response across several different DBS targets was associated with stimulation of common streamlines in a normative structural connectome. These streamlines could represent a singular indirect circuit that unifies disparate target regions and underpins at least some of their therapeutic effect.20 Network mapping approaches have also been used successfully to identify whole-brain networks incorporating both gray matter and white matter tracts that are associated with DBS treatment success from disparate targets in Parkinson’s disease and depression.21,22

The goals of this study were to 1) summarize current knowledge surrounding the effectiveness of DBS in treating extreme behaviors such as SIB and aggression in patients with ASD, and 2) evaluate neural circuitry engaged by DBS targets. The authors of all published studies of patients with extreme behaviors associated with ASD and treated with DBS were identified through a systematic review and invited to participate in the current study. A connectomic analysis of all DBS targets used to treat extreme behaviors in 4 patients with ASD was performed, and converged upon a common circuitry linking disparate targets. This multisite collaborative initiative advances understanding of DBS for the treatment of extreme behaviors in patients with ASD.

Methods

Systematic Review

The PRISMA search was performed by searching 3 electronic databases: PubMed, EMBASE, and Web of Science. This search included articles from inception to January 2020 to identify individual clinical data in patients with ASD who received DBS treatment for any indication. The following search terms were used either alone or in combination in the initial search: “autism,” “deep brain stimulation,” “neuromodulation,” and “ASD.” Inclusion criteria were articles reporting on patients with 1) a reported diagnosis of ASD; 2) DBS for the treatment of extreme refractory behaviors (specifically if the primary indication was not a movement disorder); and 3) individual patient data regarding demographics, DBS target, stimulation parameters, and reported outcome measures. Exclusion criteria included the following: 1) articles not in English; and 2) abstracts or conference proceedings. All articles reporting on DBS for patients with ASD were included, and that included case reports.

The initial title and abstract screening and subsequent full-text review were performed independently by 2 reviewers (L.M.E. and H.Y.), with disagreements resolved through conference with a senior author. Reviewed papers were cross-referenced to include missing articles. Corresponding authors of included articles were contacted for imaging sequences for connectomics.

Study Population

We performed a systematic review to identify all reports of patients with extreme behaviors associated with DBS published in the literature. This was completed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.23 Data collected included the following (where available): age at surgery, sex, comorbidities, previous treatments, ASD severity scores, DBS target, stimulation parameters, complications, and reported follow-up.

The corresponding authors of all studies were invited to participate in the current analysis by sharing pre- and postoperative imaging, including MRI and CT. Two patients identified in the systematic review and 6 additional patients (of coauthors J.C.B.I. and C.V.T.) were added for imaging analysis, due to the data being either unpublished or found outside of the systematic review search dates.

Electrode Localization and Volume of Tissue Activated Modeling

Lead-DBS software (https://www.lead-dbs.org/) was used to perform DBS electrode localization and volume of tissue activated (VTA) modeling as previously described.24 Briefly, immediate postoperative and, where available, high-resolution preoperative structural MRI acquisitions were corrected for intensity inhomogeneity and rigidly coregistered using SPM12 software (https://www.fil.ion.ucl.ac.uk/spm/software/spm12).25 The images were then nonlinearly normalized to standard space (ICBM 2009b NLIN asymmetrical) by using "effective low variance" ANTs software (http://stnava.github.io/ANTs). To correct for postoperative brain shift, an additional subcortical affine transform was performed where necessary.26 The electrodes were manually localized using the postoperative acquisition as agreed on by 2 experienced users (A.L. and J.G.) and were then warped to standard space by using the previously generated transforms. Each patient’s bilateral VTAs associated with their individual settings were modeled by first constructing a 4-compartment volume conductor model (http://iso2mesh.sourceforge.net/cgi-bin/index.cgi) that segregated peri-electrode tissue by tissue type.27 The FieldTrip-SimBio finite element model pipeline was then used to simulate the potential electric field distribution around each active contact (https://www.mrt.uni-jena.de/simbio/index.php/; http://fieldtriptoolbox.org), and a binary VTA was generated by thresholding the gradient of this distribution at 0.2 V/mm.

Functional and Structural Connectivity Mapping

The brain-wide functional and structural connectivity of each patient’s bilateral VTAs was explored using high-quality normative connectomes as previously described.2830 To assess functional connectivity, whole-brain connectivity maps of each VTA pair were computed. These maps are based on the resting-state functional MRI time course–dependent correlations of blood oxygen level–dependent signal within the seed (i.e., VTA pair) region and all the other voxels in the brain (in-house MATLAB script, version R2017b; The MathWorks Inc.) across 1000 healthy subjects from the Brain Genomics Superstruct Project data set (http://neuroinformatics.harvard.edu/gsp) (age range 18–35 years; 57% female).31

Structural connectivity was assessed by identifying all streamlines that touched the seed (i.e., VTA pair) within an approximately 12-million-fiber whole-brain tractography template (in-house MATLAB script). This template was assembled using generalized q-sampling imaging32 from a high-fidelity multishell diffusion-weighted MRI Human Connectome Project data set (http://www.humanconnectomeproject.org) of 985 healthy subjects (age range 22–35 years; 54% female).33

Statistical Analysis Identifying Common Network Components

R (https://www.r-project.org/, version 3.4.4) and RMINC (https://github.com/Mouse-Imaging-Centre/RMINC) software were used for statistical analysis. The 4 functional connectivity r-maps were converted to t-maps and, using the known p distribution, thresholded at t = 5.1 (pBonferroni corrected < 0.05) using the Bonferroni method to correct for multiple comparisons.34,35 Using this conservative approach, only voxels that showed significant functional connectivity to the seed VTAs in each individual map were considered. These 4 thresholded t-maps were binarized and then overlapped, creating a single sum map. A higher voxel value in the sum map indicated a brain area that exhibited significant functional connectivity to a greater number of VTA seeds. A similar approach was used to analyze the structural connectomes, in which individual streamline maps were also binarized (1 = touched, 0 = not touched by the seed). These individual streamline maps were summed and streamlines common to all 4 seeds were identified.

Results

Systematic Search

The initial search strategy identified 297 articles (171 after duplicates were removed) (Fig. 1). After initial title and abstract screening, a total of 18 articles underwent full-text review. An additional 2 articles not found in the database search were included after reviewing the references of the included studies. Of 20 articles undergoing full-text review, 7 articles reporting on 9 patients were included. Reasons for exclusion were due to lack of individual patient data, such as age, DBS target, stimulation parameters, or reported outcome.

FIG. 1.
FIG. 1.

PRISMA flowchart showing the search strategy and reasons for exclusion at each stage. Data added to the PRISMA template [from Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 6(7):e1000097] under the terms of the Creative Commons Attribution License. Figure is available in color online only.

Individual Participant Data

Data were extracted from 7 articles describing 9 patients who met eligibility criteria (age range 13–42 years). All patients had a diagnosis of ASD among several other comorbidities. The primary indication for DBS was SIB or aggression in 8 patients, whereas the last patient presented with OCD symptoms that progressed to SIB as well. All patients had undergone multiple attempts at pharmacological management prior to consideration of DBS. Patient demographic information can be found in Table 1.

TABLE 1.

Systematic review of patient demographics, symptoms, and DBS stimulation parameters

Authors & YearAge (yrs), SexComorbiditiesBehaviorsIndication for DBSDBS Target & Stimulation Levels
Sturm et al., 20034313, MKanner’s autism, cerebral palsySelf-aggression Self-injuryBasolat amygdala (120 µsec, 130 Hz, 2–6.5 V)
Stocco & Baizabal-Carvallo, 20143819, FMental delay, monosomy 2q & trisomy 20p, autismSelf-pickingSelf-injury & tardive dystoniaGPi (120 µsec, 80 Hz, 3.3 V)
Stocco & Baizabal-Carvallo, 20143817, MMental delay, anxiety, autismPunching of arms & legs, bitingSelf-injuryGPi (120 µsec, 100 Hz, 2.5 V) + ALIC (210 µsec, 100 Hz, 2.0 V)
Benedetti-Isaac et al., 20151727, MTBI, epilepsy, autismAggressive behavior toward selfAggressionpHyp (90 µsec, 185 Hz, 2.7 V)
Benedetti-Isaac et al., 20151716, MEpilepsy, autism, developmental delaySelf-aggressionAggressionpHyp (90 µsec, 180 Hz, 3.0 V)
Segar et al., 20153624, FDevelopmental delay, OCD, TS, autism, Kleefstra syndromeBiting hands, picking skinOCD, TSVC/VS (90 µsec, 130 Hz, 8 V)
Park et al., 20173713, MDevelopmental delay, autismSelf-mutilation, face-hitting causing fracturesSelf-injuryNAcc (90 µsec, 130 Hz, 3–5 V)
Kakko et al., 20193919, MMental retardation, autism, epilepsy, tardive dyskinesiaAggression, self-mutilation, lacerationsSelf-injury & tardive dyskinesiaGPi
Doshi et al., 20191942, FOCD, aggression, autismHitting, violent outburstsOCD & aggressionNAcc (60 µsec, 130 Hz, 2.6 V)

TBI = traumatic brain injury; TS = Tourette syndrome.

Two of the identified patients received DBS in the NAcc,19,36,37 2 in the globus pallidus internus (GPi),38,39 2 in the pHyp,17 1 in the ventral capsule/ventral striatum (VC/VS),36 1 patient had dual targets in the GPi and anterior limb of the internal capsule (ALIC),38 and 1 patient received DBS in the basolateral amygdala complex.40 All patients found in the systematic review received bilateral DBS. The GPi was chosen to improve both movement and behavioral symptoms in the 2 patients with tardive symptoms related to the pharmacological treatments targeting their SIB.

Clinical Outcomes

The primary indication for DBS among the included patients was refractory SIB or aggression. Several different outcome measurements were used to quantify behavior before and after surgery; the behaviors were measured with a number of different clinical grading scales between 2 months and 10 years. The effectiveness of DBS as measured with these scales is reported in Table 2.

TABLE 2.

Systematic review of patient treatment histories and perioperative outcomes

Authors & YearAge (yrs), SexPharmacological TxAlternative TxsPre-DBSPost-DBS (FU period)Notes
Sturm et al., 20034313, MRisperidone, topiramate, aripiprazole, lorazepamPermanent body restraintParental score of 6: restraint does not prevent skin lesions & life-threatening self-injuryParental score of 2: restraint of the wrists suffices & is well tolerated (10 mos)Battery depletion worsening restraint use to preop levels; battery replaced & restraint use decreased
Stocco & Baizabal-Carvallo, 20143819, FRisperidoneNRJHMRS 46JHMRS 4 (13 mos)NA
Stocco & Baizabal-Carvallo, 20143817, MNeuroleptics, SSRIs, anxiolytics, tricyclics, tetrabenazine, benzodiazepinesBTJHMRS 67JHMRS 19 (6 mos)Improvement in initial 3 mos, & regressed back to baseline
Benedetti-Isaac et al., 20151727, MAEDs (carbamazepine, valproic acid, clobazam, clozapine, phenobarbital); quetiapineNROAS 9OAS 1 (4 yrs)Infection, during which initial symptoms of seizure returned
Benedetti-Isaac et al., 20151716, MAEDs (valproic acid, phenytoin, carbamazepine, clonazepam, lorazepam); quetiapine; & clozapineNROAS 8OAS 1 (2 mos)Aggression controlled for 1 mo (OAS of 1), followed by regression to OAS 8, FU 6 yrs
Segar et al., 20153624, FUnnamed medicationsBTGAF 20GAF 50–60 (3 yrs)DBS lead fracture, GAF returned to 20; replacement of lead, GAF 60
Park et al., 20173713, MQuetiapine, valproate, phenytoinBT, protective helmetCGI-S 6; ABC 106; CY-BOCS 22; K-ARS 54; SRS 101CGI-S 4; ABC 40; CY-BOCS 7; K-ARS 36; SRS 98 (2 yrs)Quetiapine weaned off after 12 mos, removal of headgear, SIB 40% improved
Kakko et al., 20193919, MRisperidone, melatonin, chlorprothixene, thioxanthene, valproate, quetiapine, haloperidol, clonazepam, diazepamNRNRNRImprovement in self-mutilation
Doshi et al., 20191942, FAripiprazole, quetiapine, haloperidol, guanfacine hydrochloride, lamotrigine, alprazolam, propranolol, vitamin B6, & magnesiumRestraints while hospitalizedY-BOCS 19, HDS 20, HAS 30, SCQ 26Y-BOCS 5, HDS 15, HAS 18, SCQ 16 (12 mos)NA

ABC = Antecedent, Behavior, Consequence; AEDs = antiepileptic drugs; BT = behavioral therapy; CGI-S = Clinical Global Impressions–Severity; CY-BOCS = Children’s Y-BOCS; FU = follow-up; GAF = Global Assessment of Functioning; HAS = Hamilton Anxiety Scale; HDS = Hamilton Depression Scale; K-ARS = Korea ADHD Rating Scale; NA = not available; NR = not reported; SCQ = Social Communication Questionnaire; SRS = Social Responsiveness Scale; SSRI = selective serotonin reuptake inhibitor; Tx = treatment; Y-BOCS = Yale-Brown Obsessive-Compulsive Scale.

All patients demonstrated improvement in their clinical symptoms; this improvement was usually sustained but was transient in 2 patients. The first of the patients with transient improvement was a 17-year-old boy, who demonstrated severe body rocking and repetitive punching to his legs and arms. He received DBS to the ALIC and the GPi.38 His symptoms showed improvement on the Johns Hopkins motor stereotypy rating scale (JHMRS)41 after 3 months (from 67 to 19), but reverted to 67 after 6 months with regression to baseline symptoms. The second was a 16-year-old boy with aggression, who received DBS to the pHyp and demonstrated improvement in hostility symptoms for 1 month with an Overt Aggression Scale (OAS) score of 1, but ultimately demonstrated remission of symptoms and return to an OAS of 8 for the last 6 years of follow-up.17,42

Symptoms transiently reoccurred in 2 other patients when they encountered a complication of DBS that interrupted therapy. A 13-year-old boy with ASD, cerebral palsy, and SIB had DBS of the amygdala; his symptoms worsened to preoperative levels with battery depletion but resolved with a new battery.43 A 24-year-old woman with developmental delay, OCD, and Tourette syndrome had biting and picking symptoms that improved with VC/VS DBS, regressed with a lead fracture, and improved again after revision surgery.36

Functional Connectivity

Two patients identified through the systematic review and 6 additional patients identified through our collaborative group had appropriate preoperative and postoperative imaging for connectomics analyses. The clinical data of these patients can be found in Table 3. The 4 patients found following the systematic review had DBS of the posterior medial hypothalamus for aggression.44 The patients in the 2 unpublished cases both had DBS of the pHyp for the treatment of SIB and aggression, measured with the OAS. Table 4 outlines the DBS targets, stimulation parameters, and percent clinical improvement of these patients, with data for connectomics analysis. Clinical improvement was measured as the percentage change between the pre- and postoperative outcome measures. Targeting coordinates for preoperative planning or postoperative confirmed placement are found in Table 5.

TABLE 3.

Clinical data for patients with ASD and SIB included in connectomic analysis

Pt ID/ AuthorsAge (yrs), SexComorbiditiesDBS TargetPre-DBSPost-DBS
A; Segar et al., 20153624, FDevelopmental delay, OCD, TS, autism, Kleefstra syndromeBilat VC/VSGAF 20GAF 50–60
B; Doshi et al., 20191942, FOCD, aggression, autismBilat NAccY-BOCS 19Y-BOCS 5
C; Torres et al., 20214417, MDevelopmental delayBilat pmHypICAP (general): −43; ICAP (self): −49ICAP (general): −18; ICAP (self): −12
D; Torres et al., 20214422, MPerinatal hypoxia, developmental delayRt pmHypICAP (general): −32; ICAP (self): −16ICAP (general): −18; ICAP (self): +2
E; Torres et al., 20214423, FPerinatal hypoxia, developmental delayBilat pmHypICAP (general): −48; ICAP (self): −49ICAP (general): −24; ICAP (self): −49
F; Torres et al., 20214437, FEpilepsy, developmental delayRt pmHypICAP (general): −44; ICAP (self): −49ICAP (general): −3; ICAP (self): −12
G; Benedetti-Isaac (unpub)31, MDevelopmental delayBilat pHypOAS 9OAS 1
H; Benedetti-Isaac (unpub)29, FDevelopmental delayBilat pHypOAS 11OAS 9

ICAP = Inventory for Client and Agency Planning general aggressiveness score; pmHyp = posterior medial hypothalamus; pt = patient; unpub = unpublished.

TABLE 4.

Imaging data for patients with ASD and SIB included in connectomic analysis

Pt IDTargetMNI Coordinates (x, y, z)Rt ContactsLt ContactsPulse Width (µsec)Frequency (Hz)AmplitudeImprovement (%)
ABilat VC/VSRt (7.4, 1.8, −6.9); lt (−10.1, 6.6, −7.3)1(−) c(+)1(−) c(+)901306 V50
BBilat NAccRt (10.8, 6.1, −2.0); lt (−9.2, 6.9, −2.8)10(−) 11(+)2(−) 3(+)6013−2.6 V74
CBilat pmHypRt (1.4, −15.7, −10.8); lt (−3.6, −10.8, −7.4)0(−) c(+)4(−) c(+)2101301.8 VGeneral: 58; self: 76
DRt pmHypRt (4.3, −5.4, −7.3)0(−) 3(+)Not applicable901851.8 VGeneral: 44; self: 113
EBilat pmHypRt (−0.1, −10.8, −8.8); lt (−6.7, −8.5, −3.5)0(−) c(+)6(−) c(+)601852.5 VGeneral: 50; self: 73
FRt pmHypRt (9.9, −6.7, 9.7)2(−) c(+)Not applicable450151.3 VGeneral: 93; self: 76
GBilat pHypRt (4.3, −12.8, −6.3); lt (−0.3, −15.3, −8.9)8(−) c(+)0(−) c(+)901803.5 V88
HBilat pHypRt (0.9, −14.9, −6.6); lt (−0.5, −14.5, −8.5)8(−) c(+)0(−) c(+)901803.8 V18

MNI = Montreal Neurological Institute.

TABLE 5.

Coordinates of targeting method in DBS treatment for patients with ASD and extreme behavior

Authors & YearDBS TargetTargeting (in mm)
Sturm et al., 200343Basolat amygdalaNR
Stocco & Baizabal-Carvallo, 201438GPiNR
Stocco & Baizabal-Carvallo, 201438GPi + ALICNR
Benedetti-Isaac et al., 201517pHypPlan of MRI-based direct targeting: 2.0 lateral to AC; 3.0 posterior to AC; 5.0 below AC
Benedetti-Isaac et al., 201517pHypPlan of MRI-based direct targeting: 2.0 lateral to AC; 3.0 posterior to AC; 5.0 below AC
Segar et al., 201536Bilat VC/VSMRI-based direct targeting w/ resultant electrodes placed: 7.0 lateral to AC; rt electrode at the level of AC & lt electrode 1.0 anterior to AC; 3.0 below AC
Park et al., 201737NAccPlan of MRI-based direct targeting: 6.5 lateral to AC; 2.5 anterior to AC; 4.5 below AC
Kakko et al., 201939GPiNR
Doshi et al., 201919NAccMRI-based direct targeting w/ resultant placement of rt & lt electrodes: 6.38 & 6.58 lateral to AC; 3.51 & 4.13 anterior to AC; 4.71 & 3.74 below AC
Torres et al., 202144pmHypPlan of MRI-based direct targeting: 2.0 lateral to wall of 3rd ventricle; 0.0 relative to MCP; 2.0 below MCP

AC = anterior commissure; MCP = midcommissural point.

The functional connectivities of VTA pairs from different patients overlap in anatomical areas of shared circuitry. Within a high-fidelity brain template,45 Fig. 2 depicts the disparate DBS target locations of the 8 patients. Using functional network mapping, all 8 patients’ VTAs were found to be significantly functionally connected to the ALIC (Fig. 3). Additionally, VTA pairs in 4 of the 8 patients were significantly functionally connected to the pHyp, amygdala, insula, and anterior cingulate. Functional connectivity with distal brain regions could not be weighted according to percent clinical change due to the fact that all patients showed clinical improvement, but this was measured using different scales.

FIG. 2.
FIG. 2.

A 3D reconstruction showing the electrode placement for the 8 patients in the connectomic analyses, using a high-resolution, high-fidelity brain template.46 Renderings of the target structures are provided in 3D: NAcc in green27 and pHyp in blue.46 The DBS electrodes are identified in pairs, with the exception of patients D and F, who only received unilateral electrodes on the right. Note the considerable distance between the targets. Figure is available in color online only.

FIG. 3.
FIG. 3.

Functional network common to all 8 VTAs. A sum map showing the overlap of the 8 thresholded and binarized functional connectivity maps overlaid on coronal slices of a T1-weighted standard brain (Montreal Neurological Institute [MNI] 152). A higher voxel value in these summed images indicates a greater number of individuals, with thresholded connectivity maps overlapping in that particular area of the brain. Areas common to all 8 functional connectivity maps are shown in pink and areas covered by only 1 connectivity map are shown in light blue. Figure is available in color online only.

Structural Connectivity

There were no common streamlines identified among all 8 patients. Given that the ALIC was identified to be significantly functionally engaged in the VTA of all patients with implanted electrodes, we further probed this connectivity by using structural analyses. We assessed the extent of overlap in the structural connectivity of the ALIC in all participants with a previously published set of streamlines associated with successful treatment of OCD with DBS. The tract unifying the subthalamic nucleus and the ALIC/NAcc targets for patients treated by DBS for OCD20 was overlaid on our functional analysis (Fig. 4). Indeed, the area of perfect overlap of all 8 patients is very similar to the density projection presented by Li et al.,20 suggesting a commonly engaged structural network.

FIG. 4.
FIG. 4.

Functional network compared to patients with OCD and optimal DBS response. The summed map of the 8 functional connectivity maps is compared to the streamlines in red, which represent the common tract among patients with OCD who had optimal DBS response, identified by Li et al.20 This comparison is shown in sagittal (A), coronal (B), and axial (C) views. Figure is available in color online only.

Discussion

ASD is a complex neurodevelopmental disorder with heterogeneous symptoms and presentations. One of the most distressing manifestations is repetitive SIB causing physical harm to individuals and caregivers. DBS is an emerging option for these extreme behaviors in circumstances in which behavioral intervention and psychopharmacological treatments are insufficient.

The current study identified 9 patients with ASD reported in 7 studies, who received DBS for the treatment of extreme behaviors that mostly presented as SIB or aggression. The targets were the NAcc, GPi, ALIC, pHyp, VC/VS, and the basolateral amygdala. Through structural and functional network mapping, we show that at least 3 of these targets (NAcc, VC/VS, pHyp) in 4 patients engaged common neural circuitry.

Functional and Structural Connectivity

Connectomic analysis of 4 patients implanted with NAcc, VC/VS, or pHyp DBS electrodes provided insights into a common network underlying these targets for extreme behaviors. By mapping large-scale coordinated interactions, we were able to demonstrate that the 3 DBS target regions modulate common circuitry at the ALIC. Furthermore, some of these targets connect to a number of common distant regions such as the amygdala, insula, and anterior cingulate. Crucially, all of these areas have previously been implicated in the initiation, maintenance, or suppression of aggression and SIB.4649 By evaluating challenging or provocative auditory, visual, and other sensory stimuli, the amygdala is responsible for the context-specific initiation and modulation of aggressive behavior.46,48 Through extensive connections with the hypothalamus and insular cortex, the hypothalamic-pituitary axis and autonomic brain centers are activated to prepare for an aggressive response.46,48 Furthermore, via reinforcement-based decision-making, the NAcc and the insular cortex, along with the ventromedial, orbitofrontal, and cingulate cortices, are responsible for the modulation and/or suppression of extreme behavior, as seen in patients with ASD.47,48 In acquired lesions leading to SIB, the anterior salience network, notably the anterior cingulate, has been identified as a possible mediator of pathological behavior.50 The current analysis suggests that DBS may exert a neuromodulatory effect on a common network.46,51,52

The functional connectivity of all 8 patients, which identified the ALIC, is in close proximity and follows a similar pathway as the previously published unified tract for DBS in OCD, with fibers originating from the ventrolateral prefrontal cortices terminating in the subthalamic nucleus.20,53,54 Episodes of SIB or aggression may share common neural correlates with compulsive behavior, all demonstrating voluntary and repetitive behaviors.55 Furthermore, extreme behaviors have been associated with a need to escape from demands or undesired sensory stimuli, which is analogous to compulsions, which serve as an escape from distress or anxiety (i.e., obsessions).13,56,57

Limitations

The current study provides a summary of the sparse literature pertaining to DBS as a treatment option for extreme behaviors in patients with ASD. Although only 9 reports of this treatment exist, and only 4 patient images were used in the connectomic analysis, this work presents the first multisite collaborative effect to use a network-based approach to understand the neural circuitry implicated in DBS for SIB and aggression. The selection of targets for imaging analysis was based on availability of high-quality pre- and postoperative MRI. Comparisons between targets could potentially be possible with more data in the future.

We conducted imaging analyses in large normative data sets, which may not be representative of the connectomic profiles of individuals with ASD. Neural networks in patients who demonstrate extreme behaviors may be associated with alterations in structure and function. Future studies in data sets acquired from specific patient populations may inform the findings of the current study. Furthermore, only 8 patients underwent connectomic analysis. The conservative strategy of stringently thresholding and binarizing connectivity masks was, however, optimized to identify robust patterns of shared connectivity among seed regions. It is expected that more widespread adoption of DBS for patients with extreme behaviors will facilitate better understanding of the neural circuitry engaged by stimulation.

Conclusions

This study performed a systematic review of all patients in the literature who have received DBS for extreme behaviors associated with ASD. The individual patient data reported an improvement in SIB and aggression, as measured by several different outcome scales. Furthermore, connectomic analysis in 8 patients revealed a common functional network upon which 3 of the DBS targets converge. Novel indications for DBS are emerging, with many case studies reported in the literature. The current report advances understanding of the neural circuitry engaged by DBS for extreme behaviors in individuals with ASD.

Disclosures

Dr. Fasano is a consultant for Abbott, Ceregate, Ipsen, Medtronic, Boston Scientific, and AbbVie Inc. He has received research support from Medtronic, Boston Scientific, University of Toronto, Michael J. Fox Foundation for Parkinson’s Research, and Dystonia Medical Research Foundation, and honoraria for serving as a speaker from Abbott, UCB, Medtronic, Paladin, Sunovion, Ipsen, Boston Scientific, and AbbVie Inc. Dr. Lozano is a consultant for Medtronic, Abbott, Boston Scientific, and Insightec. He is a scientific director at Functional Neuromodulation. Dr. Bennedetti-Isaac is a proctor for Medtronic.

Author Contributions

Conception and design: Ibrahim. Acquisition of data: Yan, Elkaim, Benedetti-Isaac, Doshi, Torres, Segar, Cosgrove. Analysis and interpretation of data: Yan, Huber, Germann, Loh, Elias, Boutet. Drafting the article: Yan, Elkaim, Venetucci Gouveia, Germann, Loh, Elias, Boutet. Critically revising the article: all authors. Reviewed submitted version of manuscript: all authors. Approved the final version of the manuscript on behalf of all authors: Ibrahim. Statistical analysis: Yan, Germann, Loh. Administrative/technical/material support: Ibrahim, Fasano, Lozano, Kulkarni. Study supervision: Ibrahim.

References

  • 1

    Amaral DG, Schumann CM, Nordahl CW. Neuroanatomy of autism. Trends Neurosci. 2008;31(3):137145.

  • 2

    Lobar SL. DSM-V changes for autism spectrum disorder (ASD): implications for diagnosis, management, and care coordination for children with ASDs. J Pediatr Health Care. 2016;30(4):359365.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    Adler BA, Wink LK, Early M, et al. Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study. Autism. 2015;19(1):102106.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Raulston TJ, Hansen SG, Machalicek W, McIntyre LL, Carnett A. Interventions for repetitive behavior in young children with autism: a survey of behavioral practices. J Autism Dev Disord. 2019;49(8):30473059.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Arron K, Oliver C, Moss J, Berg K, Burbidge C. The prevalence and phenomenology of self-injurious and aggressive behaviour in genetic syndromes. J Intellect Disabil Res. 2011;55(2):109120.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Steenfeldt-Kristensen C, Jones CA, Richards C. The prevalence of self-injurious behaviour in autism: a meta-analytic study. J Autism Dev Disord. 2020;50(11):38573873.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Boser K, Higgins S, Fetherston A, Preissler MA, Gordon B. Semantic fields in low-functioning autism. J Autism Dev Disord. 2002;32(6):563582.

  • 8

    Bradley V, Hiersteiner D, Rotholz D, et al. Personal characteristics and outcomes of individuals with developmental disabilities who need support for self-injurious behaviour. J Intellect Disabil Res. 2018;62(12):10431057.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Shields MC, Akobirshoev I, Dembo RS, Mitra M. Self-injurious behavior among adults with ASD: hospitalizations, length of stay, and costs of resources to deliver care. Psychiatr Serv. 2019;70(6):457464.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Malone RP, Waheed A. The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism. Drugs. 2009;69(5):535548.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Sabus A, Feinstein J, Romani P, Goldson E, Blackmer A. Management of self-injurious behaviors in children with neurodevelopmental disorders: a pharmacotherapy overview. Pharmacotherapy. 2019;39(6):645664.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Antonacci DJ, Manuel C, Davis E. Diagnosis and treatment of aggression in individuals with developmental disabilities. Psychiatr Q. 2008;79(3):225247.

  • 13

    Iwata BA, Dorsey MF, Slifer KJ, Bauman KE, Richman GS. Toward a functional analysis of self-injury. J Appl Behav Anal. 1994;27(2):197209.

  • 14

    Fitzpatrick SE, Srivorakiat L, Wink LK, Pedapati EV, Erickson CA. Aggression in autism spectrum disorder: presentation and treatment options. Neuropsychiatr Dis Treat. 2016;12:15251538.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15

    Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry. 2002;159(8):13371346.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16

    Dennison A, Lund EM, Brodhead MT, Mejia L, Armenta A, Leal J. Delivering home-supported applied behavior analysis therapies to culturally and linguistically diverse families. Behav Anal Pract. 2019;12(4):887898.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17

    Benedetti-Isaac JC, Torres-Zambrano M, Vargas-Toscano A, et al. Seizure frequency reduction after posteromedial hypothalamus deep brain stimulation in drug-resistant epilepsy associated with intractable aggressive behavior. Epilepsia. 2015;56(7):11521161.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18

    Franzini A, Marras C, Ferroli P, Bugiani O, Broggi G. Stimulation of the posterior hypothalamus for medically intractable impulsive and violent behavior. Stereotact Funct Neurosurg. 2005;83(2-3):6366.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Doshi PK, Hegde A, Desai A. Nucleus accumbens deep brain stimulation for obsessive-compulsive disorder and aggression in an autistic patient: a case report and hypothesis of the role of nucleus accumbens in autism and comorbid symptoms. World Neurosurg. 2019;125:387391.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20

    Li N, Baldermann JC, Kibleur A, et al. A unified connectomic target for deep brain stimulation in obsessive-compulsive disorder. Nat Commun. 2020;11(1):3364.

  • 21

    Schlaepfer TE, Bewernick BH, Kayser S, Hurlemann R, Coenen VA. Deep brain stimulation of the human reward system for major depression—rationale, outcomes and outlook. Neuropsychopharmacology. 2014;39(6):13031314.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22

    Horn A, Reich M, Vorwerk J, et al. Connectivity predicts deep brain stimulation outcome in Parkinson disease. Ann Neurol. 2017;82(1):6778.

  • 23

    Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.

  • 24

    Horn A, Kühn AA. Lead-DBS: a toolbox for deep brain stimulation electrode localizations and visualizations. Neuroimage. 2015;107:127135.

  • 25

    Friston K, Ashburner J, Kiebel S, Nichols T. Penny W, ed. Statistical Parametric Mapping: The Analysis of Functional Brain Images. Elsevier;2011.

    • Search Google Scholar
    • Export Citation
  • 26

    Avants BB, Tustison NJ, Song G, Cook PA, Klein A, Gee JC. A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage. 2011;54(3):20332044.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27

    Ewert S, Plettig P, Li N, et al. Toward defining deep brain stimulation targets in MNI space: a subcortical atlas based on multimodal MRI, histology and structural connectivity. Neuroimage. 2018;170:271282.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    Elias GJB, Boutet A, Joel SE, et al. Probabilistic mapping of deep brain stimulation: insights from 15 years of therapy. Ann Neurol. 2021;89(3):426443.

  • 29

    Elias GJB, Giacobbe P, Boutet A, et al. Probing the circuitry of panic with deep brain stimulation: connectomic analysis and review of the literature. Brain Stimul. 2020;13(1):1014.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30

    Coblentz A, Elias GJB, Boutet A, et al. Mapping efficacious deep brain stimulation for pediatric dystonia. J Neurosurg Pediatr. 2021;27(3):346356.

  • 31

    Fox MD, Buckner RL, Liu H, Chakravarty MM, Lozano AM, Pascual-Leone A. Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases. Proc Natl Acad Sci U S A. 2014;111(41):E4367E4375.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32

    Yeh FC, Wedeen VJ, Tseng WY. Generalized q-sampling imaging. IEEE Trans Med Imaging. 2010;29(9):16261635.

  • 33

    Glasser MF, Sotiropoulos SN, Wilson JA, et al. The minimal preprocessing pipelines for the Human Connectome Project. Neuroimage. 2013;80:105124.

  • 34

    Fox MD. Mapping symptoms to brain networks with the human connectome. N Engl J Med. 2018;379(23):22372245.

  • 35

    Mansouri AM, Germann J, Boutet A, et al. Identification of neural networks preferentially engaged by epileptogenic mass lesions through lesion network mapping analysis. Sci Rep. 2020;10(1):10989.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36

    Segar DJ, Chodakiewitz YG, Torabi R, Cosgrove GR. Deep brain stimulation for the obsessive-compulsive and Tourette-like symptoms of Kleefstra syndrome. Neurosurg Focus. 2015;38(6):E12.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37

    Park HR, Kim IH, Kang H, et al. Nucleus accumbens deep brain stimulation for a patient with self-injurious behavior and autism spectrum disorder: functional and structural changes of the brain: report of a case and review of literature. Acta Neurochir (Wien). 2017;159(1):137143.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38

    Stocco A, Baizabal-Carvallo JF. Deep brain stimulation for severe secondary stereotypies. Parkinsonism Relat Disord. 2014;20(9):10351036.

  • 39

    Kakko K, Bjelogrlic-Laakso N, Pihlakoski L, Lehtimäki K, Järventausta K. Tardive dyskinesia should not be overlooked. J Child Adolesc Psychopharmacol. 2019;29(1):7274.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 40

    Sturm V, Fricke O, Bührle CP, et al. DBS in the basolateral amygdala improves symptoms of autism and related self-injurious behavior: a case report and hypothesis on the pathogenesis of the disorder. Front Hum Neurosci. 2013;6:341.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41

    Miller JM, Singer HS, Bridges DD, Waranch HR. Behavioral therapy for treatment of stereotypic movements in nonautistic children. J Child Neurol. 2006;21(2):119125.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 42

    Yudofsky SC, Silver JM, Jackson W, Endicott J, Williams D. The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry. 1986;143(1):3539.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 43

    Sturm V, Lenartz D, Koulousakis A, et al. The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. J Chem Neuroanat. 2003;26(4):293299.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 44

    Torres CV, Blasco G, Navas García M, et al. Deep brain stimulation for aggressiveness: long-term follow-up and tractography study of the stimulated brain areas. J Neurosurg. 2021;134(2):366375.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 45

    Neudorfer C, Germann J, Elias GJB, Gramer R, Boutet A, Lozano AM. A high-resolution in vivo magnetic resonance imaging atlas of the human hypothalamic region. Sci Data. 2020;7(1):305.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 46

    Gouveia FV, Hamani C, Fonoff ET, et al. Amygdala and hypothalamus: historical overview with focus on aggression. Neurosurgery. 2019;85(1):1130.

  • 47

    Blair RJ. The neurobiology of impulsive aggression. J Child Adolesc Psychopharmacol. 2016;26(1):49.

  • 48

    Siever LJ. Neurobiology of aggression and violence. Am J Psychiatry. 2008;165(4):429442.

  • 49

    Westlund Schreiner M, Klimes-Dougan B, Begnel ED, Cullen KR. Conceptualizing the neurobiology of non-suicidal self-injury from the perspective of the Research Domain Criteria Project. Neurosci Biobehav Rev. 2015;57:381391.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 50

    Yan H, Elkaim L, Loh A, et al. Lesions causing self-injurious behavior engage putative networks modulated by deep brain stimulation. Brain Stimul. 2021;14(2):273276.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 51

    Gouveia FV, Germann J, de Morais R, et al. Longitudinal changes after amygdala surgery for intractable aggressive behavior: clinical, imaging genetics, and deformation-based morphometry study—a case series. Neurosurgery. 2021;88(2):E158E169.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 52

    Gouveia FV, Germann J, Devenyi GA, et al. Refractoriness of aggressive behaviour to pharmacological treatment: cortical thickness analysis in autism spectrum disorder. BJPsych Open. 2020;6(5):e85.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 53

    Coenen VA, Schlaepfer TE, Varkuti B, et al. Surgical decision making for deep brain stimulation should not be based on aggregated normative data mining. Brain Stimul. 2019;12(6):13451348.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 54

    Dougherty DD, Rezai AR, Carpenter LL, et al. A randomized sham-controlled trial of deep brain stimulation of the ventral capsule/ventral striatum for chronic treatment-resistant depression. Biol Psychiatry. 2015;78(4):240248.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 55

    Barnard-Brak L, Rojahn J, Richman DM, Chesnut SR, Wei T. Stereotyped behaviors predicting self-injurious behavior in individuals with intellectual disabilities. Res Dev Disabil. 2015;36C:419-427.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 56

    Figee M, Pattij T, Willuhn I, et al. Compulsivity in obsessive-compulsive disorder and addictions. Eur Neuropsychopharmacol. 2016;26(5):856868.

  • 57

    Starcevic V, Berle D, Brakoulias V, et al. Functions of compulsions in obsessive-compulsive disorder. Aust N Z J Psychiatry. 2011;45(6):449457.

  • Collapse
  • Expand

Schematics of transseptal interforniceal resection of a superiorly recessed colloid cyst. ©Mark Souweidane, published with permission. See the article by Tosi et al. (pp 813–819).

  • View in gallery
    FIG. 1.

    PRISMA flowchart showing the search strategy and reasons for exclusion at each stage. Data added to the PRISMA template [from Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 6(7):e1000097] under the terms of the Creative Commons Attribution License. Figure is available in color online only.

  • View in gallery
    FIG. 2.

    A 3D reconstruction showing the electrode placement for the 8 patients in the connectomic analyses, using a high-resolution, high-fidelity brain template.46 Renderings of the target structures are provided in 3D: NAcc in green27 and pHyp in blue.46 The DBS electrodes are identified in pairs, with the exception of patients D and F, who only received unilateral electrodes on the right. Note the considerable distance between the targets. Figure is available in color online only.

  • View in gallery
    FIG. 3.

    Functional network common to all 8 VTAs. A sum map showing the overlap of the 8 thresholded and binarized functional connectivity maps overlaid on coronal slices of a T1-weighted standard brain (Montreal Neurological Institute [MNI] 152). A higher voxel value in these summed images indicates a greater number of individuals, with thresholded connectivity maps overlapping in that particular area of the brain. Areas common to all 8 functional connectivity maps are shown in pink and areas covered by only 1 connectivity map are shown in light blue. Figure is available in color online only.

  • View in gallery
    FIG. 4.

    Functional network compared to patients with OCD and optimal DBS response. The summed map of the 8 functional connectivity maps is compared to the streamlines in red, which represent the common tract among patients with OCD who had optimal DBS response, identified by Li et al.20 This comparison is shown in sagittal (A), coronal (B), and axial (C) views. Figure is available in color online only.

  • 1

    Amaral DG, Schumann CM, Nordahl CW. Neuroanatomy of autism. Trends Neurosci. 2008;31(3):137145.

  • 2

    Lobar SL. DSM-V changes for autism spectrum disorder (ASD): implications for diagnosis, management, and care coordination for children with ASDs. J Pediatr Health Care. 2016;30(4):359365.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    Adler BA, Wink LK, Early M, et al. Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study. Autism. 2015;19(1):102106.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Raulston TJ, Hansen SG, Machalicek W, McIntyre LL, Carnett A. Interventions for repetitive behavior in young children with autism: a survey of behavioral practices. J Autism Dev Disord. 2019;49(8):30473059.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Arron K, Oliver C, Moss J, Berg K, Burbidge C. The prevalence and phenomenology of self-injurious and aggressive behaviour in genetic syndromes. J Intellect Disabil Res. 2011;55(2):109120.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Steenfeldt-Kristensen C, Jones CA, Richards C. The prevalence of self-injurious behaviour in autism: a meta-analytic study. J Autism Dev Disord. 2020;50(11):38573873.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Boser K, Higgins S, Fetherston A, Preissler MA, Gordon B. Semantic fields in low-functioning autism. J Autism Dev Disord. 2002;32(6):563582.

  • 8

    Bradley V, Hiersteiner D, Rotholz D, et al. Personal characteristics and outcomes of individuals with developmental disabilities who need support for self-injurious behaviour. J Intellect Disabil Res. 2018;62(12):10431057.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Shields MC, Akobirshoev I, Dembo RS, Mitra M. Self-injurious behavior among adults with ASD: hospitalizations, length of stay, and costs of resources to deliver care. Psychiatr Serv. 2019;70(6):457464.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Malone RP, Waheed A. The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism. Drugs. 2009;69(5):535548.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Sabus A, Feinstein J, Romani P, Goldson E, Blackmer A. Management of self-injurious behaviors in children with neurodevelopmental disorders: a pharmacotherapy overview. Pharmacotherapy. 2019;39(6):645664.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Antonacci DJ, Manuel C, Davis E. Diagnosis and treatment of aggression in individuals with developmental disabilities. Psychiatr Q. 2008;79(3):225247.

  • 13

    Iwata BA, Dorsey MF, Slifer KJ, Bauman KE, Richman GS. Toward a functional analysis of self-injury. J Appl Behav Anal. 1994;27(2):197209.

  • 14

    Fitzpatrick SE, Srivorakiat L, Wink LK, Pedapati EV, Erickson CA. Aggression in autism spectrum disorder: presentation and treatment options. Neuropsychiatr Dis Treat. 2016;12:15251538.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15

    Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry. 2002;159(8):13371346.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16

    Dennison A, Lund EM, Brodhead MT, Mejia L, Armenta A, Leal J. Delivering home-supported applied behavior analysis therapies to culturally and linguistically diverse families. Behav Anal Pract. 2019;12(4):887898.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17

    Benedetti-Isaac JC, Torres-Zambrano M, Vargas-Toscano A, et al. Seizure frequency reduction after posteromedial hypothalamus deep brain stimulation in drug-resistant epilepsy associated with intractable aggressive behavior. Epilepsia. 2015;56(7):11521161.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18

    Franzini A, Marras C, Ferroli P, Bugiani O, Broggi G. Stimulation of the posterior hypothalamus for medically intractable impulsive and violent behavior. Stereotact Funct Neurosurg. 2005;83(2-3):6366.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Doshi PK, Hegde A, Desai A. Nucleus accumbens deep brain stimulation for obsessive-compulsive disorder and aggression in an autistic patient: a case report and hypothesis of the role of nucleus accumbens in autism and comorbid symptoms. World Neurosurg. 2019;125:387391.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20

    Li N, Baldermann JC, Kibleur A, et al. A unified connectomic target for deep brain stimulation in obsessive-compulsive disorder. Nat Commun. 2020;11(1):3364.

  • 21

    Schlaepfer TE, Bewernick BH, Kayser S, Hurlemann R, Coenen VA. Deep brain stimulation of the human reward system for major depression—rationale, outcomes and outlook. Neuropsychopharmacology. 2014;39(6):13031314.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22

    Horn A, Reich M, Vorwerk J, et al. Connectivity predicts deep brain stimulation outcome in Parkinson disease. Ann Neurol. 2017;82(1):6778.

  • 23

    Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.

  • 24

    Horn A, Kühn AA. Lead-DBS: a toolbox for deep brain stimulation electrode localizations and visualizations. Neuroimage. 2015;107:127135.

  • 25

    Friston K, Ashburner J, Kiebel S, Nichols T. Penny W, ed. Statistical Parametric Mapping: The Analysis of Functional Brain Images. Elsevier;2011.

    • Search Google Scholar
    • Export Citation
  • 26

    Avants BB, Tustison NJ, Song G, Cook PA, Klein A, Gee JC. A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage. 2011;54(3):20332044.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27

    Ewert S, Plettig P, Li N, et al. Toward defining deep brain stimulation targets in MNI space: a subcortical atlas based on multimodal MRI, histology and structural connectivity. Neuroimage. 2018;170:271282.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    Elias GJB, Boutet A, Joel SE, et al. Probabilistic mapping of deep brain stimulation: insights from 15 years of therapy. Ann Neurol. 2021;89(3):426443.

  • 29

    Elias GJB, Giacobbe P, Boutet A, et al. Probing the circuitry of panic with deep brain stimulation: connectomic analysis and review of the literature. Brain Stimul. 2020;13(1):1014.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30

    Coblentz A, Elias GJB, Boutet A, et al. Mapping efficacious deep brain stimulation for pediatric dystonia. J Neurosurg Pediatr. 2021;27(3):346356.

  • 31

    Fox MD, Buckner RL, Liu H, Chakravarty MM, Lozano AM, Pascual-Leone A. Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases. Proc Natl Acad Sci U S A. 2014;111(41):E4367E4375.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32

    Yeh FC, Wedeen VJ, Tseng WY. Generalized q-sampling imaging. IEEE Trans Med Imaging. 2010;29(9):16261635.

  • 33

    Glasser MF, Sotiropoulos SN, Wilson JA, et al. The minimal preprocessing pipelines for the Human Connectome Project. Neuroimage. 2013;80:105124.

  • 34

    Fox MD. Mapping symptoms to brain networks with the human connectome. N Engl J Med. 2018;379(23):22372245.

  • 35

    Mansouri AM, Germann J, Boutet A, et al. Identification of neural networks preferentially engaged by epileptogenic mass lesions through lesion network mapping analysis. Sci Rep. 2020;10(1):10989.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36

    Segar DJ, Chodakiewitz YG, Torabi R, Cosgrove GR. Deep brain stimulation for the obsessive-compulsive and Tourette-like symptoms of Kleefstra syndrome. Neurosurg Focus. 2015;38(6):E12.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37

    Park HR, Kim IH, Kang H, et al. Nucleus accumbens deep brain stimulation for a patient with self-injurious behavior and autism spectrum disorder: functional and structural changes of the brain: report of a case and review of literature. Acta Neurochir (Wien). 2017;159(1):137143.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38

    Stocco A, Baizabal-Carvallo JF. Deep brain stimulation for severe secondary stereotypies. Parkinsonism Relat Disord. 2014;20(9):10351036.

  • 39

    Kakko K, Bjelogrlic-Laakso N, Pihlakoski L, Lehtimäki K, Järventausta K. Tardive dyskinesia should not be overlooked. J Child Adolesc Psychopharmacol. 2019;29(1):7274.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 40

    Sturm V, Fricke O, Bührle CP, et al. DBS in the basolateral amygdala improves symptoms of autism and related self-injurious behavior: a case report and hypothesis on the pathogenesis of the disorder. Front Hum Neurosci. 2013;6:341.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41

    Miller JM, Singer HS, Bridges DD, Waranch HR. Behavioral therapy for treatment of stereotypic movements in nonautistic children. J Child Neurol. 2006;21(2):119125.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 42

    Yudofsky SC, Silver JM, Jackson W, Endicott J, Williams D. The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry. 1986;143(1):3539.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 43

    Sturm V, Lenartz D, Koulousakis A, et al. The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. J Chem Neuroanat. 2003;26(4):293299.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 44

    Torres CV, Blasco G, Navas García M, et al. Deep brain stimulation for aggressiveness: long-term follow-up and tractography study of the stimulated brain areas. J Neurosurg. 2021;134(2):366375.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 45

    Neudorfer C, Germann J, Elias GJB, Gramer R, Boutet A, Lozano AM. A high-resolution in vivo magnetic resonance imaging atlas of the human hypothalamic region. Sci Data. 2020;7(1):305.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 46

    Gouveia FV, Hamani C, Fonoff ET, et al. Amygdala and hypothalamus: historical overview with focus on aggression. Neurosurgery. 2019;85(1):1130.

  • 47

    Blair RJ. The neurobiology of impulsive aggression. J Child Adolesc Psychopharmacol. 2016;26(1):49.

  • 48

    Siever LJ. Neurobiology of aggression and violence. Am J Psychiatry. 2008;165(4):429442.

  • 49

    Westlund Schreiner M, Klimes-Dougan B, Begnel ED, Cullen KR. Conceptualizing the neurobiology of non-suicidal self-injury from the perspective of the Research Domain Criteria Project. Neurosci Biobehav Rev. 2015;57:381391.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 50

    Yan H, Elkaim L, Loh A, et al. Lesions causing self-injurious behavior engage putative networks modulated by deep brain stimulation. Brain Stimul. 2021;14(2):273276.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 51

    Gouveia FV, Germann J, de Morais R, et al. Longitudinal changes after amygdala surgery for intractable aggressive behavior: clinical, imaging genetics, and deformation-based morphometry study—a case series. Neurosurgery. 2021;88(2):E158E169.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 52

    Gouveia FV, Germann J, Devenyi GA, et al. Refractoriness of aggressive behaviour to pharmacological treatment: cortical thickness analysis in autism spectrum disorder. BJPsych Open. 2020;6(5):e85.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 53

    Coenen VA, Schlaepfer TE, Varkuti B, et al. Surgical decision making for deep brain stimulation should not be based on aggregated normative data mining. Brain Stimul. 2019;12(6):13451348.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 54

    Dougherty DD, Rezai AR, Carpenter LL, et al. A randomized sham-controlled trial of deep brain stimulation of the ventral capsule/ventral striatum for chronic treatment-resistant depression. Biol Psychiatry. 2015;78(4):240248.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 55

    Barnard-Brak L, Rojahn J, Richman DM, Chesnut SR, Wei T. Stereotyped behaviors predicting self-injurious behavior in individuals with intellectual disabilities. Res Dev Disabil. 2015;36C:419-427.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 56

    Figee M, Pattij T, Willuhn I, et al. Compulsivity in obsessive-compulsive disorder and addictions. Eur Neuropsychopharmacol. 2016;26(5):856868.

  • 57

    Starcevic V, Berle D, Brakoulias V, et al. Functions of compulsions in obsessive-compulsive disorder. Aust N Z J Psychiatry. 2011;45(6):449457.

Metrics

All Time Past Year Past 30 Days
Abstract Views 2672 982 0
Full Text Views 847 675 76
PDF Downloads 906 684 81
EPUB Downloads 0 0 0